[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351615-105":59,"doc-detail-351615-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-the-microbiome-in-gynecological-cancers-implications-for-diagnosis-and-treatment","The role of the microbiome in gynecological cancers - implications for diagnosis and treatment","","Gynecological malignancies, including cancers of the cervix, ovary, endometrium, vulva, and vagina, represent a major global health burden. While traditional explanations emphasize genetic mutation, hormonal imbalance, and chronic viral infection, this review highlights the microbiome’s central role in carcinogenesis. Microbial dysbiosis—loss of beneficial Lactobacillus and enrichment of anaerobes—links to chronic inflammation, immune modulation, epithelial barrier disruption, metabolite toxicity, and estrogen metabolism via the estrobolome.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-the-microbiome-in-gynecological-cancers-implications-for-diagnosis-and-treatment/351615/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-the-microbiome-in-gynecological-cancers-implications-for-diagnosis-and-treatment/351615.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does microbiome dysbiosis relate to gynecological cancer development?","Question",{"text":112,"@type":113},"The review links dysbiosis—reduced beneficial Lactobacillus and increased anaerobic organisms—to carcinogenesis through chronic inflammation, immune modulation, epithelial barrier loss, metabolite toxicity, and altered estrogen metabolism via the estrobolome.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which gynecological cancers are discussed as being affected by microbiome changes?",{"text":117,"@type":113},"It discusses cancers of the cervix, ovary, endometrium, vulva, and vagina, describing how microbiome disruption in both the gut and reproductive tract associates with HPV persistence and tumor microenvironment remodeling.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic and treatment approaches does the review propose from a microbiome perspective?",{"text":121,"@type":113},"It emphasizes microbial signatures as potential non-invasive biomarkers for early diagnosis, prognosis, and therapy monitoring, and it considers microbiome-based adjunct therapies such as probiotics, prebiotics, dietary manipulation, vaginal microbiota transplantation, and fecal microbiota transplantation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351615,1790479361,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","TYPE Review  \nPUBLISHED 23 April 2026  \nDOI 10.3389/fimmu.2026.1718883  \nOPEN ACCESS  \nEDITED BY  \nSheila Spada,  \nHospital Physiotherapy Institutes (IRCCS), Italy  \nREVIEWED BY  \nElena Niculet,  \nDunarea de Jos University, Romania Sudhir Kumar,  \nEmory University, United States  \n*CORRESPONDENCE  \nPrecious Adeoye Oyedokun  \n [preciousoyedokun21@gmail.com](preciousoyedokun21@gmail.com)[ ](preciousoyedokun21@gmail.com)Roland Eghoghosoa Akhigbe  \n [reakhigbe@gmail.com](reakhigbe@gmail.com)[ ](reakhigbe@gmail.com)RECEIVED 04 October 2025 REVISED 17 March 2026 ACCEPTED 01 April 2026 PUBLISHED 23 April 2026  \nCITATION  \nOyedokun PA, Oyeleke BT, Akanji OO, Oyelaran AO, O KP, Akanbi GB, Oyedokun PO, Oyedokun MD, Naomi CC, Imoleayo OO and Akhigbe RE (2026) The role of the microbiome in gynecological cancers:  \nimplications for diagnosis and treatment. Front. Immunol. 17:1718883 .  \ndoi: 10.3389/fimmu.2026.1718883  \nCOPYRIGHT  \n© 2026 Oyedokun, Oyeleke, Akanji, Oyelaran, O, Akanbi, Oyedokun, Oyedokun, Naomi, Imoleayo and Akhigbe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe role of the microbiome in gynecological cancers:  \nimplications for diagnosis and treatment  \nPrecious Adeoye Oyedokun 1,2,3*, Bobola Timothy Oyeleke 4, Onigbinde Oluwanisola Akanji 5, Abraham Ololade Oyelaran 4, Kehinde Philip O 4, Grace Bosede Akanbi 1,  \nPhilip Olagbede Oyedokun 3,6, Marvelous Dasola Oyedokun 3,7, Chikezie Chinelo Naomi 8, Oyeniran Oluwatosin Imoleayo 9 and Roland Eghoghosoa Akhigbe 1,2*  \n1 Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria,  \n2 Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria, 3Axon Plus Consulting, Ogbomoso, Oyo State, Nigeria, 4 Department of Medical Laboratory Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria,  \n5 Department of Anatomy, Nile University, Abuja, Nigeria, 6 Department of Computer Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria, 7 Department of Nursing Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria, 8 Department of Anatomy, University of Ilorin, Ogbomoso, Oyo State, Nigeria, 9 Department of Kinesiology and Integrative Physiology, Michigan Technological University, Houghton, MI, United States  \nGynecological malignancies such as cancer of the cervix, ovary, endometrium, vulva, and vagina pose a severe global health burden. Although conventionally attributed to genetic mutation, hormonal imbalance, and chronic viral infection, including high-risk human papillomavirus, recent evidence suggests that the human microbiome plays a central role in their pathogenesis and development. This review summarizes existing evidence that microbial dysbiosis, speciﬁcally the depletion of beneﬁcial Lactobacillus species and overrepresentation of anaerobic organisms such as Fusobacterium, Atopobium, and Sneathia, is implicated in carcinogenesis pathways. These include chronic inﬂammation, immune modulation, loss of epithelial barrier integrity, microbial metabolite toxicity, and estrogen metabolism by the estrobolome. Dysbiosis in the gut and reproductive tract has been associated with HPV persistence, tumor microenvironment remodeling, and immune surveillance/therapy resistance. Consequently, microbial signatures are being investigated as a potentially successful non-invasive biomarker for early diagnosis, prognosis, and monitoring of therapy in gynecological oncology. In addition, emergent microbiome-based therapies are being c","cbCaijazpGiBr2Ni","https://ap.wps.com/l/cbCaijazpGiBr2Ni","pdf",1127193,17,"English","# Introduction\n## Global burden of gynecological cancers\n## Pathogenesis and conventional etiological factors\n# Microbiome-driven mechanisms\n## Dysbiosis and carcinogenesis pathways\n## Immune modulation and tumor microenvironment\n# Diagnostic and therapeutic implications\n## Non-invasive microbial biomarkers\n## Microbiome-based adjunct therapies","[{\"question\":\"How does microbiome dysbiosis relate to gynecological cancer development?\",\"answer\":\"The review links dysbiosis—reduced beneficial Lactobacillus and increased anaerobic organisms—to carcinogenesis through chronic inflammation, immune modulation, epithelial barrier loss, metabolite toxicity, and altered estrogen metabolism via the estrobolome.\"},{\"question\":\"Which gynecological cancers are discussed as being affected by microbiome changes?\",\"answer\":\"It discusses cancers of the cervix, ovary, endometrium, vulva, and vagina, describing how microbiome disruption in both the gut and reproductive tract associates with HPV persistence and tumor microenvironment remodeling.\"},{\"question\":\"What diagnostic and treatment approaches does the review propose from a microbiome perspective?\",\"answer\":\"It emphasizes microbial signatures as potential non-invasive biomarkers for early diagnosis, prognosis, and therapy monitoring, and it considers microbiome-based adjunct therapies such as probiotics, prebiotics, dietary manipulation, vaginal microbiota transplantation, and fecal microbiota transplantation.\"}]","The role of the microbiome in gynecological cancers - implications for diagnosis and treatment | PDF",1790094953,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb623402eb9ee62945ed3c54128da718.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da7a3a7464e787ca97f3f8ad66c07e77.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d6c6089f7686240b916cbc75d29913c.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a58347b848c11561d638275e336f79f.webp",980,1385]